This compound is a quinazolinamine derivative with a stereocenter, featuring nitro, ether, and halogen substituents. It serves as a pharmaceutical intermediate, primarily used in research and manufacturing contexts.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 314771-88-5
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)formamide (Afatinib Impurity)
research compound
(2R)-3,3-dimethylbutan-2-amine hydrochloride
pharmaceutical intermediate
2-(2-methoxyethoxy)ethanamine
pharmaceutical intermediate
2-(Bromomethyl)-4-chloro-1-nitrobenzene
pharmaceutical intermediate
2-Ethoxy-5-nitropyridine
pharmaceutical intermediate
(R)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine
pharmaceutical intermediate
N-(3-chloro-4-fluorophenyl)-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine
UXAZURVGMXJLSO-NSHDSACASA-N
C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)F)Cl)[N+](=O)[O-]